China Pharma Holdings CPHI
NYSE CPHI
$0.64 -0.02 (-2.62%)
As of: Oct 1, 2026 · 3:53 PM EDT

China Pharma Holdings (CPHI) Change in Accured Expenses (2010 - 2026)

Updated

China Pharma Holdings' Change in Accured Expenses came in at $191,211 for Q2 2026, up 5.9% from $180,487 a year earlier.

Analysis

China Pharma Holdings (CPHI) Change in Accured Expenses (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, China Pharma Holdings reported Change in Accured Expenses of $541,028, down 30.1% year-over-year; for FY2025, it was $465,753, up 8.0% from FY2024.

  • Going back by year, Change in Accured Expenses was $431,215 in FY2024 (+67.3%), $257,778 in FY2023 (-62.8%), $692,190 in FY2022 (+66.7%) and $415,309 in FY2021.
  • The five-year range for quarterly Change in Accured Expenses is -$450,887 (Q1 2023) to $804,339 (Q4 2022).
  • Year-over-year, Change in Accured Expenses increased in three of the last four quarters, with growth averaging 27.0%.
  • The fastest year-over-year change in Change in Accured Expenses over five years came in Q3 2023 (growth of 940.4%), and the weakest in Q2 2023 (a decline of 83.2%).
  • Business Quant data shows CPHI's Change in Accured Expenses at -$14,258 (Q1 2026), $432,777 (Q4 2025) and -$68,702 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.20 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -251.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 901.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 338.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 222.50 Mn
10 China Pharma Holdings 26.34 Mn 25.22 Mn 83,566.00 191,211.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 191,211.00
Mar 31, 2026 -14,258.00
Dec 31, 2025 432,777.00
Sep 30, 2025 -68,702.00
Jun 30, 2025 180,487.00
Mar 31, 2025 -78,809.00
Dec 31, 2024 729,131.00
Sep 30, 2024 -56,482.00
Jun 30, 2024 106,548.00
Mar 31, 2024 -347,982.00
Dec 31, 2023 420,886.00
Sep 30, 2023 262,045.00
Jun 30, 2023 25,734.00
Mar 31, 2023 -450,887.00
Dec 31, 2022 804,339.00
Sep 30, 2022 25,186.00
Jun 30, 2022 153,558.00
Mar 31, 2022 -290,893.00
Dec 31, 2021 207,099.00
Sep 30, 2021 -239,290.00
API Access

China Pharma Holdings Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=CPHI&period=max&api_key=YOUR_API_KEY